Named Patient Medicines Supplier

Regulated Named Patient Supply for Case-Based Medicine Access
Oddway International is a named patient medicines supplier supporting regulated, case-based access to pharmaceutical products for licensed hospitals, treating physicians, NGOs, and institutional programs.
We operate within recognized named patient supply frameworks, enabling access to medicines for individual cases where approved products may not yet be locally available, subject to destination-country regulations and documentation requirements.
Understanding Named Patient Supply
Named patient supply refers to a regulated mechanism that allows licensed healthcare institutions to request medicines for a specific, identified patient under applicable regulatory provisions.
This process is typically used when:
- No approved alternative is available locally
- The medicine is required on a case-by-case basis
- Access is permitted under national or regional regulations
Oddway International’s role is limited to regulated pharmaceutical sourcing and export coordination, delivered through our pharmaceutical export services.
Named Patient Programs – India-Based Supply Partner
As a named patient program supplier in India, Oddway International supports international and domestic programs by coordinating compliant pharmaceutical supply from India to approved destinations.
Our support is designed for:
- Hospitals and institutional buyers
- NGOs and humanitarian organizations
- Government-approved access programs
- Licensed treating physicians acting through institutions
All named patient programs are evaluated based on regulatory feasibility, licensing status, and documentation completeness, consistent with our pharmaceutical wholesale services framework.
Our Role as a Named Patient Medicines Supplier
Oddway International’s responsibilities within named patient frameworks include:
- Coordinating manufacturer-authorized sourcing
- Supporting case-based medicine supply requests
- Managing export documentation and regulatory alignment
- Facilitating compliant international logistics
- Ensuring supply is limited strictly to approved cases
Logistics and delivery are handled through international medicine shipping, ensuring compliance with destination-country requirements.
Regulatory and Ethical Framework
All name patient supply activities supported by Oddway International are governed by:
- Destination-country regulations
- Institutional approvals
- Case-specific documentation
- Ethical and responsible supply principles
Oddway International does not provide medical advice, treatment recommendations, or patient counseling.
How Named Patient Supply Fits Within Our Services
Named patient support is provided as a regulated, informational access pathway
This service complements—but does not replace—our core capabilities in:
- pharmaceutical export services
- pharmaceutical wholesale services
- international medicine shipping
Each service operates under one clear intent, ensuring compliance and clarity.
Compliance Declaration
Oddway International does not provide medical advice. Named patient supply is supported strictly through licensed entities and in accordance with applicable laws and regulatory requirements.
Frequently Asked Questions
A named patient medicines supplier supports regulated, case-based access to medicines by coordinating sourcing and export for approved individual cases through licensed healthcare institutions, in line with applicable regulations.
All named patient supply is conducted strictly between licensed entities such as hospitals, NGOs, and approved institutions.
Named patient supply is used when a required medicine is not locally available and access is permitted under regulatory provisions for an identified individual case, subject to documentation and approvals.
No. Named patient supply is a case-based, non-commercial access mechanism and is distinct from commercial distribution, retail pharmacy activity, or online medicine sales.
Yes. As a named patient program supplier in India, Oddway International supports regulated programs by coordinating compliant pharmaceutical supply and export for approved institutional requests.